A Study to Assess the Safety and Efficacy of a Single Dose of UBX0101 in Patients With Osteoarthritis of the Knee
Clinical trial NCT04129944 · COMPLETED
Trial details
- NCT number
- NCT04129944
- Sponsor
- Unity Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-30
- Primary completion
- 2020-05-20
- Enrollment
- 183
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.